Neutralizing inflammatory cytokines (TNF) can reduce the level of FGF23 in animal models of chronic kidney disease (CKD) and high levels of FGF23 are associated with increased cardiovascular morbidity and mortality in patients with CKD (Egli-Spichtig et al., 2019). Here, FGF23 is linked to chronic kidney disease.